Non-biopsy Methods to Determine Hepatic Fibrosis

Overview

Journal J Med Life

Specialty General Medicine

Date 2010 Jan 30

PMID 20108754

Authors

Carmen Fierbinteanu-Braticevici

Monica Purcarea

Affiliations

Soon will be listed here.

Abstract

The prognosis and clinical management of chronic liver diseases are highly dependent on the extent of liver fibrosis. Bigger the fibrosis, worse the prognosis; and bigger the risk of progression to cirrhosis. In current practice, liver biopsy is most frequently performed to assess the grade of inflammation and stage of fibrosis thereby providing prognostic information on which to base treatment decisions upon. Liver biopsy is becoming more and more useless in the management of chronic liver disease due to large sampling error, consistent inter-observer disagreement, high emotional cost of patient, enormous health care commitment in case of rare but possible severe complications, the fact that it is a snapshot of a process that is everything but a frozen one. Therefore, every methodology that avoids performing this invasive procedure is welcome. The purpose of this article is to present the noninvasive evaluation of patients with chronic liver disease as an alternative of liver biopsy in the assessment of hepatic structure and function.

References

Ryder S, Irving W, Jones D, Neal K, Underwood J . Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut. 2004; 53(3):451-5. PMC: 1773967. DOI: 10.1136/gut.2003.021691. View

Lim A, Patel N, Hamilton G, Hajnal J, Goldin R, Taylor-Robinson S . The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology. 2003; 37(4):788-94. DOI: 10.1053/jhep.2003.50149. View

Shaheen A, Myers R . Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology. 2007; 46(3):912-21. DOI: 10.1002/hep.21835. View

Wright M, Thursz M, Pullen R, Thomas H, Goldin R . Quantitative versus morphological assessment of liver fibrosis: semi-quantitative scores are more robust than digital image fibrosis area estimation. Liver Int. 2003; 23(1):28-34. DOI: 10.1034/j.1600-0676.2003.01771.x. View

Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R . Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med. 2004; 10(4):429-34. DOI: 10.1038/nm1006. View

Huwart L, Sempoux C, Salameh N, Jamart J, Annet L, Sinkus R . Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 2007; 245(2):458-66. DOI: 10.1148/radiol.2452061673. View

Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F . Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. Gastroenterology. 2007; 132(2):709-19. DOI: 10.1053/j.gastro.2006.12.041. View

Talwalkar J, Kurtz D, Schoenleber S, West C, Montori V . Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007; 5(10):1214-20. DOI: 10.1016/j.cgh.2007.07.020. View

Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M . Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005; 128(2):343-50. DOI: 10.1053/j.gastro.2004.11.018. View

10.

Gebo K, Herlong H, Torbenson M, Jenckes M, Chander G, Ghanem K . Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology. 2002; 36(5 Suppl 1):S161-72. DOI: 10.1053/jhep.2002.36989. View

11.

Morra R, Munteanu M, Bedossa P, Dargere D, Janneau J, Paradis V . Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2007; 26(6):847-58. DOI: 10.1111/j.1365-2036.2007.03427.x. View

12.

Huang H, Shiffman M, Cheung R, Layden T, Friedman S, Abar O . Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology. 2006; 130(6):1679-87. DOI: 10.1053/j.gastro.2006.02.032. View

13.

Parkes J, Guha I, Roderick P, Rosenberg W . Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol. 2006; 44(3):462-74. DOI: 10.1016/j.jhep.2005.10.019. View

14.

Boulanger Y, Amara M, Lepanto L, Beaudoin G, Nguyen B, Allaire G . Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed. 2003; 16(3):132-6. DOI: 10.1002/nbm.818. View

15.

Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F . Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005; 41(1):48-54. DOI: 10.1002/hep.20506. View

16.

Deeks J . Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001; 323(7305):157-62. PMC: 1120791. DOI: 10.1136/bmj.323.7305.157. View

17.

Melton A, Datta A, Yee Jr H . [Ca2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1. Am J Physiol Gastrointest Liver Physiol. 2005; 290(1):G7-13. DOI: 10.1152/ajpgi.00337.2005. View

18.

Vanheule E, Geerts A, Reynaert H, Van Vlierberghe H, Geerts A, De Vos M . Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy. Liver Int. 2008; 28(1):107-16. DOI: 10.1111/j.1478-3231.2007.01629.x. View

19.

Cadranel J, Rufat P, Degos F . Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000; 32(3):477-81. DOI: 10.1053/jhep.2000.16602. View

20.

Shaheen A, Myers R . Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection. HIV Clin Trials. 2008; 9(1):43-51. DOI: 10.1310/hct0901-43. View